Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q3 2022 call → NOWe need to determine if management explains the company's business direction by narrating what its counterparties are themselves doing and scaling. The key is whether management's forward account is substantially about the growth, expansion, ramp, adoption, or program build-out of specific customers/partners that the company already supplies, and that this is presented as the driver of the company's coming volume. Let's analyze the transcript. Management discusses: - Challenging macro environment, customers deferring purchases. - Recurring revenue increased. - Launch of AwareID. - Craig Herman's initiatives: expediting customer adoption, partner program, realigning revenue org. - They mention specific customers: "One of our long-standing customers has almost doubled their spend with us." Also, "we just recently signed a customer that last year or this current year that just ended had about 600,000, 700,000 transactions as they are committed minimal. They went over it. And so we renewed them for next year, 2 million transactions. So almost a 3x increase of them." That is about a specific customer's growth in transactions. - Also, "we've seen a couple of government customers receive approved to operate status after extended pilot phases and in one case, a sizable delay." That indicates customers moving from pilot to operational. - They talk about Latin America success with financial institutions using Knomi. But is the forward account substantially about counterparties' own trajectories? The management's outlook is more about their own actions: launching AwareID, optimizing go-to-market, customer success, partner program, etc. They mention some customer expansions, but it's not the central narrative. They also talk about macro headwinds and delays. The question asks: "does a substantial part of management's forward account consist of reporting on the growth, expansion, ramp, adoption, or program build-out of specific customers, partners, licensees, distributors, payers, operators, or programs the company ALREADY SUPPLIES OR SERVES, such that the company's own coming volume is presented as a consequence of those parties' own trajectories rather than of the company's selling effort?" Management does mention a specific customer doubling spend and another tripling transactions, but these are brief mentions.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.